Why the study?
Does the sirolimus-eluting stent improve in-lesion late loss in patients with in-stent restenosis of a native coronary artery?
Does the sirolimus-eluting stent improve in-lesion late loss in patients with in-stent restenosis of a native coronary artery?
Sirolimus-eluting stents are effective and safe for treating in-stent restenosis, showing low in-lesion late loss and low rates of recurrent restenosis.
No takes yet. Share an insight, caveat, or question.
May support sirolimus-eluting stents in in-stent restenosis; leaves open randomized confirmation of comparative efficacy.
Neumann et al. (2005) studied this question.